Pharma Payment Rankings

How these rankings are built

Every ranking on PlainPharmaWatch is computed directly from the CMS Open Payments database for the most recent published program year. The Centers for Medicare and Medicaid Services collects payment reports from applicable manufacturers and group purchasing organizations under the Physician Payments Sunshine Act (Section 6002 of the Affordable Care Act). Pharmaceutical and medical-device companies are required by federal law to disclose any transfers of value made to physicians and teaching hospitals — consulting fees, speaking fees, food and beverage, travel reimbursement, royalties, research support, education grants, and ownership interests.

We ingest the full annual release, group by applicable manufacturer (AMGPO), recipient state, recipient NPI, and payment category, then sort. The result is six independent leaderboards: largest paying companies, highest-spending states, states with highest per-physician spending, top recipient physicians, top recipient teaching hospitals, and companies with the most discrete transactions. Each leaderboard is generated server-side from the same canonical companies, states, and recipients tables that power the rest of the site, so a rank shown here is reconcilable to the row-level totals on each detail page.

What the rankings tell you

Aggregate payment totals reveal which manufacturers are most active in marketing-related interactions with U.S. healthcare providers. The top ten manufacturers consistently account for a substantial share of the annual total — concentration that reflects both the size of the underlying pharmaceutical market and the prevalence of high-touch sales models for specialty drugs. State rankings expose geographic concentration: a small number of states (often those with large teaching-hospital systems, research-intensive academic medical centers, and dense physician populations) capture the bulk of disbursements. Per-physician rankings normalize for state size and surface the states where the average physician is paid the most.

Recipient rankings — the top physicians and top teaching hospitals — should be read carefully. Receiving payments from pharma companies is legal and common; many high-ranking individuals are clinical researchers running active trials, surgical specialists receiving royalties on devices they helped invent, or department chairs running CME programs underwritten by industry. The Sunshine Act exists to make these flows transparent, not to imply wrongdoing. The dataset is the same one journalists, regulators, and academic researchers cite when investigating payment-prescribing relationships, and we present it without editorial scoring.

Source and update cadence

CMS publishes Open Payments data annually, with each release covering the prior calendar year and appearing roughly twelve months after the reporting period ends. Between annual releases CMS occasionally issues corrected snapshots when disputes change the record set. PlainPharmaWatch updates within days of each official release. Historical years are preserved for trend comparisons, but the rankings page reflects the most recent program year unless otherwise noted.

For full provenance, every page on PlainPharmaWatch carries a citation to the underlying CMS dataset; the methodology page describes ingestion, normalization, and limitations in detail. Browse the leaderboards below to drill into companies, states, or recipients of interest, or jump directly to the full company directory, state directory, or top recipients list.

Methodological choices behind the leaderboards

Every leaderboard on this page makes a deliberate choice about how to aggregate the underlying CMS records, and those choices are worth understanding before drawing conclusions. The largest-companies ranking sums every reported general-payment record by applicable manufacturer or applicable group purchasing organization. We use the canonical applicable-manufacturer or GPO identifier reported to CMS rather than a marketing brand name, so subsidiaries that file under their parent corporation's identifier are combined; subsidiaries that file under independent identifiers appear as separate entries. The highest-payment-states leaderboard aggregates by the recipient's primary state of practice, which is taken from the National Plan and Provider Enumeration System for individual physicians and from the institutional address for teaching hospitals.

The highest-per-physician leaderboard divides each state's total physician-routed payments by the count of distinct physician recipients within the state, producing an average dollars-per-physician figure. This normalization controls for state population and physician workforce size, but it does not control for the mix of specialties within the state — a state with disproportionately many oncologists or cardiologists will tend to show a higher per-physician average because those specialties generate more consulting and speaker-bureau activity than primary-care specialties. For specialty-specific cuts, drill into individual physician detail pages.

The top-recipient physicians and top-recipient hospitals leaderboards rank by absolute total payments received. Physician rankings can move dramatically between annual releases when a clinical-trial principal investigator's program funding ramps or concludes; teaching-hospital rankings are more stable because institutional aggregates pool across many simultaneously active programs. The most-transactions ranking counts discrete payment records rather than dollar totals, surfacing manufacturers that route many small payments (typical of meal-and-beverage and travel-reimbursement programs) rather than a small number of large payments.